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Abstract. Coated microneedles have significant potential for use in transdermal delivery 
applications. In this paper, we describe the fabrication of microneedle master templates 
using microstereolithography techniques and subsequently use a commercial injection 
moulding process to replicate these microneedles in biocompatible cyclic olefin polymer 
(COP) materials. Notably, the 475 m-tall needle designs feature a shallow pit or reservoir 
at the tip, thereby providing both a target and holder for incoming droplets that are deposited 
using a piezoelectric inkjet printer. Using this design, no tilting or rotation of the needle 
array is required during the filling process. In the preliminary tests reported here, the 
reservoir is filled with a FITC-labelled dye that acts as a model drug, and ex-vivo skin tests 
are used to verify skin penetration, the transfer of this model drug to the skin and to measure 
the reliability of the needles themselves. To our knowledge, this is the first time that such an 
inkjet-filled, reservoir-tipped microneedle has been demonstrated.
Keywords - Microneedles, injection moulding, piezoelectric inkjet dispensing, bioMEMS, 
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Patch-based transdermal drug delivery is highly attractive due to its needle-free nature and potential 
for self-administration, with corresponding benefits in increased patient compliance, reduced clinical 
time, elimination of needle-stick injuries and sharps waste. However, the outermost layer of the skin 
poses a formidable barrier to the transdermal delivery of drugs and vaccines. Despite being relatively 
thin (typically 10-20m thick), the stratum corneum prevents the passage of all but a small number of 
low molecular weight drugs, currently estimated at fewer than 20 products [1-3] . However, this 
specialized and constantly renewing layer of cornified and keratin-rich cell bodies is not the only 
hurdle to overcome. The skin barrier is further fortified by a high number of cell-cell junctions in the 
epidermal layers beneath [4]. To efficiently deliver drugs across these multiple barriers in the 
epidermis of mammalian skin new transdermal drug delivery technologies are needed.
Microneedle technologies have been proposed as a potential solution to this issue. Consisting of short, 
sharp structures generally measuring less than 1 mm in length and provided in arrays of anything up 
to several thousand per square centimetre, microneedle patches can be used to penetrate the stratum 
corneum and deliver drugs or vaccines to the viable epidermis immediately below in a painless and 
minimally invasive manner [5, 6]. 
These arrays can be deployed in four primary delivery mechanisms. Firstly, simple solid microneedles 
can be used to painlessly perforate the skin before the subsequent application of a topical formulation 
or patch [7]. Secondly, drugs and vaccines can be infused in small volumes and at low flowrates 
through hollow microneedles in much the same manner as with conventional hypodermic needles [8]. 
Thirdly, a number of techniques such as brushing, dipping, inkjet printing or spraying can be used to 
coat microneedles with a formulation that is dried and later dissolved in the skin [9]. Lastly, 
dissolvable microneedles (DMNs) are moulded from a biodegradable polymer into which a drug or 
vaccine is mixed and which dissolves once in contact with the moist epidermal layers beneath the 
stratum corneum [10].
1.1 Low-cost transdermal drug delivery (TDD) device fabrication
Microneedles have traditionally been fabricated using techniques borrowed from the semiconductor 
industry, such as photolithography, thin-film deposition, wet and dry etching, and wafer dicing [11, 
12]. Although precise and in some cases capable of producing complex and ultrasharp devices that 
integrate additional functionality such as fluidics and electronics, semiconductor-based processing is 
expensive, often slow, and tends to use materials that may not be accepted as standard in the medical 
devices industry. Therefore, there is growing interest in the low-cost, rapid fabrication of transdermal 








































































drug delivery systems (TDDS), using a combination of one or more techniques for fabrication, 
replication and/or functionalization [13]. Micromoulding has attracted wide interest for low-cost 
microneedle fabrication, using both solid [14] and biodegradable [15] materials. In particular, 
biodegradable microneedles have the advantage that the drug or vaccine of interest may be mixed 
with the structural material. This provides a single-step fabrication process and a low-cost delivery 
route with the potential for relatively high dose loading [16], and significant progress is being made in 
addressing issues such as polymer processing temperatures, biomechanical strength and long-term 
stability during storage [17]. Alternative processes that may provide low-temperature fabrication, such 
as droplet air blowing [18] and drawing lithography [19], are also emerging as candidates for low-cost 
needle manufacture.
Among more commercially established technologies, injection moulding is commonly used for the 
manufacture of biomedical components [20, 21], and has been shown to be capable of replicating the 
small features and sharp tips usually associated with microneedles, in low cost, high-throughput 
facilities. 3M Corporation have demonstrated transdermal drug delivery using both solid [22-24] and 
hollow [25] injection moulded microneedles, fabricated from medical-grade, liquid crystalline 
polymer materials under their Microstructured Transdermal System (MTS) brand. Others have used 
injection moulding techniques to create microneedles in materials such as polycarbonate, 
polyethylene terephthalate (PET), cyclic olefin copolymer (COC), and polyoxymethylene [26-29]. 
3D printing approaches such as two-photon polymerization (2PP), microstereolithography (μSL) or 
digital light processing (DLP) are also emerging as a new way of making microneedles, and can now 
achieve very precise geometries [30]. Ultra-sharp polymer microneedles specifically designed to 
perforate the round window membrane (RWM) of the inner ear with a view to precisely delivering 
therapeutics across that membrane were fabricated using 2PP [31], achieving a tip radius of 500 nm. 
2PP was also employed to fabricate 630 nm-diameter microneedles for use in single call analysis from 
a drop cast resist material [32], while μSL was used to develop 700 μm tall biodegradable 
microneedles for chemotherapeutic drug delivery [33]. 3D printing has also been used to fabricate a 
curved microneedle array for treatment of trigger finger, and to subsequently deliver diclofenac gel 
using the 'poke and patch' approach [34] .
These low-cost 3D printing approaches can be merged with non-contact coating techniques, 
particularly piezoelectric inkjet deposition [35, 36], to form fully functional transdermal drug delivery 
patches. The team at University of North Carolina and North Carolina State University, have 
combined μSL and elastomeric vacuum casting to create microneedles from Gantrez polymers, which 
were then coated with various formulations using piezoelectric printing [37-39]. Later, that group 
used a combination of injection moulding, drawing lithography and piezoelectric printing to 
demonstrate poly(glycolic) acid microneedles that were coated with itraconazole and voriconazole 
formulations [40, 41]. In all cases, deposition was facilitated by carefully arranging the needles so that 







































































a flat face of the needle was positioned at 90o to the incoming droplet path, and in [41], loading was 
maximised by rotating the needle midway through the process in order to coat both sides. In [42], μSL 
printing and inkjet disposition were combined for applications in insulin delivery.
Clearly, in studies performed to date, multiple coating steps or careful positioning of the microneedle 
array substrate is required in order to obtain sufficiently high dose loading. An alternative method of 
increasing dose loading, without using substrate orientation or multiple deposition passes, could be by 
modifying the structure of the microneedle tip itself to receive and to hold larger volumes of 
formulation. In this paper, we therefore describe the fabrication of microneedle master templates 
using μSL techniques and show that it is possible to use a commercial injection moulding process to 
replicate these microneedles in cyclic olefin polymers (COPs), with shape and sharpness approaching 
that of the original master template. Notably, the microneedles have been designed to incorporate a 
shallow pit or reservoir at the tip, thereby providing both a target and holder for incoming droplets 
that are deposited using a piezoelectric inkjet printer. This reservoir retains the formulation close to 
the tip, and also has the potential to increase loading capacity. In the preliminary tests reported here, 
the reservoir is filled with a FITC-labelled dye that acts as a model drug, and ex-vivo skin tests are 
used to verify the transfer of this model drug to the skin. In addition, we measure the reliability of the 
needles themselves. To our knowledge, this is the first time that such a reservoir-tipped microneedle 
has been demonstrated. 
2 Experimental Details
2.1 Microneedle master – design and fabrication
Microneedle master templates were produced using microstereolithography (SL), i.e the spatially 
controlled solidification of a liquid resin by direct ultraviolet photo-polymerization in a series of 
layers. The microneedles were designed as 475 m tall, cone-like structures with a sidewall angle of 
73o, at a pitch of 1.4 mm, and incorporating a 180 m deep reservoir (volume approximately 59 pL) 
near the tip, figure 1. This bevel-like, offset design positions the drug cargo close to the tip, whilst 
retaining the tip itself for better skin penetration and needle reliability.  
Needles were printed using a custom-built SLA system using a 375 nm UV-laser diode and a 
scanning galvanometer mirror to solidify a UV-curing adhesive (07A22X-8, Sony CID Corp., Tokyo). 
First, a square base for the arrays was printed using 4 x 100 m thick layers. Next, 5 m thick layers 
were used to create the lower body of the needle, while the layer thickness was reduced to 2 m for 
the last 15 layers. This smaller step height results in increased accuracy and tip sharpness. Arrays of 5 
x 5 needles were produced, and the printing time for one array was roughly 5 hours, depending on the 
final resolution and chosen layer thickness.







































































Figure 1. CAD drawing of the microneedle master design.
2.2 Injection Moulding
Using these templates, arrays of sharp polymer microneedle structures were then manufactured at 
STRATEC Consumables GmbH (Anif, Austria), using a proprietary replication process based on their 
former CD/DVD production equipment. This involved mounting a customized insert on an existing 
CD mould, and using an isothermal injection moulding process without compression. A Sumitomo 
Disc 40E Disc Molding Subsystem (Sumitomo SHI Demag Plastics Machinery North America, Inc., 
OH, USA) was used for moulding; the mould temperature was 80oC and the clamping pressure set at 
25 tons, figure 2. The material was Zeonor 1020R cyclic olefin polymer (Zeon Europe GmbH, 
Dusseldorf, Germany), which we have already shown to be biocompatible according to ISO 10993-5 
and USP 87 standards [43], and the process resulted in easy de-moulding as well as sharp needle tips. 
A milling procedure was then used to partially isolate each electrode from the frame, leaving the array 
lightly tethered on two thin supports for subsequent easy removal.
Figure 2. Sumitomo Disc 40E Disc Moulding Subsystem [44].









































































The injection moulded needles were then filled using a Dimatix DMP 2800 drop-on-demand inkjet 
printer (FujiFilm Dimatix, Santa Clara, CA).  An actuation pulse of amplitude 15 V and duration of 
11.5 µs, and a maximum jetting frequency of 5000 Hz was used. Nominal drop volume was 10pL and 
the escape velocity of the droplets was between 2-8 m/s.  
The ink was a mixture of 5 wt %  fluorescein isothiocyanate (FITC) dye for imaging purposes, 22 wt 
% water and a 73 wt % mixture of volatile solvents. The dry mass of one drop (FTIC) was 0.536 ng 
per drop. The ink temperature was set to 50 °C, and the printbed was heated to 30 oC. Ambient 
laboratory conditions (20 °C and relative humidity of 50 %) prevailed. Loaded needles were then dried 
at 100 oC for 30 minutes.
For these initial tests and to aid with subsequent visualisation of the dye transfer to skin, just one 
column of each array (i.e 5 x 1 needles) was loaded. Initially the array was aligned with one axis of the 
printer, and the coordinates of the first needle in the target row were selected using the printhead 
camera and Dimatix internal software. Subsequent needles were coated by moving the nozzle along 
the row, in steps equal to the microneedle pitch, starting from the location of this first needle. A 
variety of deposition settings and skin insertion times were used as specified in Table 1 below.
2.4 Skin preparation and array applications
Following protocols approved by the Clinical Research Ethics Committee of the Cork Teaching 
Hospitals (CREC), human skin was excised following plastic surgical operations and stored at -80 oC 
until needed. It was then defrosted, trimmed of excess fat, cut into squares of approximately 3 cm x 3 
cm, and mounted on an artificial tissue substrate (Wound Closure Pad, Limbs & Things, Bristol, UK) 
to mimic the mechanical properties of underlying tissue.
Spring-loaded applicators are often used to apply microneedle devices to the skin in a consistent 
manner [45]. In this case, a custom-built applicator was used to ensure repeatable and reliable skin 
penetration. This applicator uses a spring constant of 274 N/m, and generated impact energy of (0.4 
+/- 0.01) J/cm2. 
Methylene blue staining is a technique routinely used to assess microneedle penetration [46], and was 
also used here to confirm skin breach. During this procedure, uncoated arrays (i.e. with empty tip 
reservoirs) were applied to the skin with the applicator and left in place for 20 minutes. After removal, 
the impact area was stained with a 1% solution (w/vol) of methylene blue (Sigma-Aldrich, Dublin, 
Ireland) for 90 minutes. Excess dye was removed with tissue, the skin was cleaned with water and 
70% ethanol, before being tape stripped ten times (9040 Paper Tape, 3M Corp., St Paul, MN) in order 
to ensure than any remaining dye was present under the stratum corneum and not on its surface. 







































































To test the fluorescent dye-loaded microneedle arrays, the applicator maintained a force of (5.90 +/- 
0.54) N on the needle array for a specific time after impact. Six arrays were tested at varying insertion 
times, see Table 1.






1 2 20 1,072 10
2 4 40 2,144 10
3 4 40 2,144 5
4 6 60 3,216 5
5 6 60 3,216 1
6 8 80 4,288 1
Table 1. Needle loading parameters and skin insertion times for each sample type.
2.5 Inspection and classification
Optical microscope images of the methylene blue-stained impact area after insertion and skin 
washing/stripping were recorded using a digital camera. A thorough inspection of the fluorescent dye-
loaded needles was also performed. Each of the 6 injection moulded arrays featured 21 needles – a 
total of 126 needles. Of these, one column (five needles) on each array was filled. Each needle, 
whether filled or not, was individually inspected both before and after skin insertion, from a variety of 
angles and orientations, using microscopes including stereozoom (SZX12, Olympus Corp., Tokyo, 
Japan),  digital (VHX-200, Keyence Ltd., Milton Keynes, UK)  and fluorescent (Olympus BX51). 
The purpose of this exercise was to visually confirm delivery of the dye and to assess any damage that 
occurred during the insertion process.
Following application to ex-vivo tissue as outlined above, fluorescent microscopy was used to 
examine the transfer of material from filled needles to skin. Pictures of the surface of the skin were 
taken with the fluorescent microscope at exposure times (ETs) of 50 ms, 100 ms and 200 ms.
Finally, the skin samples were cut using a scalpel along the line of the holes left by the loaded 
needles. Images of the cross section of the skin were taken with the fluorescent microscope to assess 
the diffusion of the dye underneath the stratum corneum.
In order to quantify the intensity of the fluorescence as a function of array insertion time, an image 
analysis was performed using the software ImageJ [47]. A region of interest (ROI) was defined by 
firstly selecting an initial pixel at the boundary of the fluorescent area, and then using the software’s 
‘Wand’ tool to identify a contiguous area based on the condition that all the boundary pixel values 








































































must be in the range initial pixel value ± tolerance, where the tolerance value was set to 22 and kept 
constant for each image analysis.
To remove the influence of the background signal, the mean intensity per pixel of the region outside 
of the ROI was calculated for each image, and subtracted from each pixel within the ROI. The total 
intensity was calculated by summing this net fluorescence per pixel over all pixels within the ROI.
3 Results and Discussion
3.1 Microneedle fabrication using SL and injection moulding
Images of the SL master structure and injection-moulded needle array are illustrated in figure 3. 
Note the milled slot and tethers linking the array to the support frame. 
   
(a)








































































       
(b)
(c)
Figure 3. (a) SEM image of SL master structure, (b) SEM of injection moulded microneedle, and (c) 
injection moulded array prior to removal from support frame.
3.2 Filling of needle reservoirs
Background fluorescence from the epoxy material itself prevented a thorough analysis of the polymer 
microneedle coating using fluorescence microscopy, and so droplet location and consistency was 
assessed using optical microscopy, figure 4. In general all of the incoming material was positioned in 
the reservoir and little or no splashing was observed on or around the needle.








































































   
Figure 4. Left: example of reservoir-tipped microneedles after the filling procedure. Right: Top-down 
perspective of filled microneedles.
3.3 Skin Penetration and Delivery
Penetration markings remaining after the staining procedure described in Section 2.4 are shown in 
figure 5. 
  
Figure 5.  Ex-vivo skin sample stained with methylene blue dye following microneedle array insertion. 
The needle pitch is 1.4 mm.
Methylene blue is hydrophilic with a low molecular weight, and the intact, hydrophobic stratum 
corneum cannot take up the stain. Once the stratum corneum barrier is disrupted, the dye diffuses 
through the newly created pores to the underlying epidermis, where it binds to the tissue due to its 
high affinity for proteins. Therefore, the presence of blue markings after microneedle application is 
generally regarded as definitive proof of successful insertion. Note that 19 marks are present, while 








































































there are 21 needles on the array, and a closer inspection revealed that two needles on the right-hand 
side of the array were damaged during handling, resulting in no penetration at these locations.
To establish if the fluorescent dye was delivered inside the skin, analysis of both the microneedle 
arrays and skin samples was performed as outlined in Section 2.5. Figure 6 illustrates the needle 
already shown in figure 4 after skin insertion for ten minutes. 
      
Figure 6. Microneedle of figure 3 (left) shown after skin insertion.
The dye almost completely disappeared from the tip of the microneedle, indicating that it was 
transferred to the skin. Further evidence of transdermal delivery is evident from the fluorescent photos 
of the skin samples. As shown in figures 7 and 8, the points where the skin was pierced by the needles 
are clearly visible and the fluorescent dye has diffused beneath the stratum corneum. 
Figure 7. Cross-section of skin sample. The point of needle insertion and diffusion of dye beneath the 
surface is clearly visible. 
To quantify the dye delivery process as outlined in Section 2.5, the background contribution was 
removed and the value of the fluorescence recalculated for the entire row of dye-loaded needles, 
figure 8.  Exposure time for all of this analysis was 50 ms (as longer exposures tended to exhibit 








































































saturation) and the resultant intensity data is shown in figure 9. Two independent variables are 
present, i.e. droplet quantity and skin insertion time. In general, the results are as expected, i.e. 
increasing either the number of droplets or the skin insertion time results in an increase in fluorescent 
intensity.
        
Figure 8. Delivery to skin. Left: En-face image. Right: cross-section of the same skin sample; the 
boundary between skin surface and underlying tissue is marked. Images taken after ten minutes 
insertion at 50 ms exposure time. The needle pitch is 1.4 mm.
Figure 9. Fluorescence intensity as a function of skin insertion time and needle loading. 
The only exception to this trend is for ten-minute insertion times, where the fluorescence intensities 
are much higher than for one- or five-minute insertion times, but do not vary significantly as a 








































































function of loading volume. This may be caused by the skin becoming saturated after that period, 
meaning that additional dye delivery does not alter the fluorescence readings.
This is the first demonstration of an injection-moulded, reservoir-tipped microneedle. However, this 
preliminary proof-of-concept work is limited in scope and additional tests of larger sample sets are 
required in order to draw definitive statistical conclusions. Secondly, while useful for initial device 
validation during process development, this fluorescence method is somewhat limited due to its 
projection of a three-dimensional diffusion pattern onto a two-dimensional image. Future 
development will require more accurate quantification of drug loading and release profiles through the 
use of assays such as HPLC analysis and in-vitro/in-vivo models. However, these results verify 
transdermal delivery of the model drug from reservoir-tipped needles. Delivery trends are as expected, 
and show that this novel needle design offers a promising method of transdermal delivery. 
3.4 Reliability
During post-insertion inspection, it was noted that a significant number of needles suffered minor tip 
damage during the skin delivery tests. One array was damaged after removal due to manual handling, 
and, of the other five arrays that competed a full inspection, 33% of all needles indicated some degree 
of tip damage. This was always confined to the tip region and no major structural failures of the body 
of the microneedles were observed. Needle tips seemed to be flattened or crushed, i.e. no breakage or 
brittle fracture was seen. It is therefore unlikely that any material remained in the skin after use, and, 
as these are single-use devices, this tip blunting should not pose a major issue. It is nevertheless 
undesirable and other polymers and/or tip designs should be investigated.
4 Conclusion
This paper has shown that two low-cost techniques – injection moulding and inkjet printing – may be 
combined to produce coated microneedles for transdermal drug and vaccine delivery. Initially, SL 
was used to produce 475 m tall microneedles, which featured a flat-bottomed pit or reservoir located 
close to the needle tip. This reservoir increases loading capacity and removes the need to tilt samples 
in order to present a flat surface to the incoming droplet.
These designs were then replicated at a commercial injection-moulding facility, using a modified 
process based on former CD/DVD production equipment. An inkjet printer was used to deposit a 
model drug (FITC) into the reservoir, and needle arrays were inserted into ex-vivo human skin using 
an applicator. Subsequent fluorescence analysis showed the results were largely in line with 
expectations, i.e. intensity increased with needle loading and skin insertion time. This work shows 
that it is feasible to rapidly produce large quantities of coated microneedle arrays, using automated 
processes, in medical-grade material and at low cost.
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